Medical Devices Meet EU HTA: When Regulatory Approval is No Longer the Finish Line
For years, European medical device companies have largely built their evidence strategies around regulatory approval, clinical adoption, and country specific reimbursement. The EU Health Technology Assessment Regulation is beginning to disrupt this sequence. As selected ...read more
published on Oct 27, 2026